Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| §112 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACKSON, SHAWQUIA | 1 | 77.9% | -3.4% |
| ATKINSON, JOSHUA ALEXANDER | 1 | 57.1% | +34.0% |
| FAY, ZOHREH ALEMZADEH | 1 | 51.8% | -6.7% |
| COLEMAN, BRENDA LIBBY | 1 | 74.7% | +15.7% |
| CHANDRAKUMAR, NIZAL S | 1 | 72.6% | +18.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18293826 | STABLE PHARMACEUTICAL COMPOSITIONS OF APOMORPHINE | ATKINSON, JOSHUA ALEXANDER | 73d overdue |
| 18547618 | A QUINOLONE COMPOUND IN SOLID FORMS AND PROCESSES FOR THE PREPARATION THEREOF | COLEMAN, BRENDA LIBBY | 9d |
| 17912228 | FORMULATION COMPRISING HIF PROLYL HYDROXYLASE INHIBITORS | CHANDRAKUMAR, NIZAL S | 61d |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1612 | 1 |
| 1617 | 1 |
| 1624 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18797055 | PROCESS FOR THE PREPARATION OF MIRABEGRON FREE FROM GENOTOXIC IMPURITIES | JACKSON, SHAWQUIA | 1626 | §103 | Final Rejection | 21d | Pending | Aug 07, 2024 |
| 18293826 | STABLE PHARMACEUTICAL COMPOSITIONS OF APOMORPHINE | ATKINSON, JOSHUA ALEXANDER | 1612 | §103 | Non-Final OA | 73d overdue | Pending | Jan 31, 2024 |
| 18578843 | PHARMACEUTICAL COMPOSITIONS OF OZANIMOD | FAY, ZOHREH ALEMZADEH | 1617 | §103 | Non-Final OA | 30d overdue | Pending | Jan 12, 2024 |
| 18547618 | A QUINOLONE COMPOUND IN SOLID FORMS AND PROCESSES FOR THE PREPARATION THEREOF | COLEMAN, BRENDA LIBBY | 1624 | §112 | Non-Final OA | 9d | Pending | Aug 23, 2023 |
| 17912228 | FORMULATION COMPRISING HIF PROLYL HYDROXYLASE INHIBITORS | CHANDRAKUMAR, NIZAL S | 1625 | DPOther | Final Rejection | 61d | Pending | Sep 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial